H-YLLEMLWRL-OH

Ref. 3D-PP43179

Información del producto

• Nombre: H-YLLEMLWRL-OH
• Sinónimos: NH2-Tyr-Leu-Leu-Glu-Met-Leu-Trp-Arg-Leu-OH

Descripción

Peptide H-YLLEMLWRL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YLLEMLWRL-OH include the following: Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens Z Xiao, Z Ye, VS Tadwal, M Shen , EC Ren - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-05171-w Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes YL Tang, JH Lu, L Cao, MH Wu, SP Peng - Brazilian Journal of , 2008 - SciELO Brasilhttps://www.scielo.br/j/bjmbr/a/h8fY8VZ68tkhHL9XzmjXdcM/?lang=en Amino acid substitutions in the epstein-barr virus associated oncogene latent membrane protein 1 impact upon the immunogenicity of Nasopharyngeal S ZHENYING - 2009 - core.ac.ukhttps://core.ac.uk/download/pdf/48646391.pdf Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies S Gottschalk , OL Edwards, U Sili - Blood, The Journal , 2003 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/101/5/1905/106579 Identification of a Cytotoxic T-Lymphocyte S Cross, N Raab-Traub, R Khanna, N Kienzle - J. Virol, 1998 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=f97f454300fa91e48556a68e3ac85503e09696bf Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers RR Yuan, P Wong, MR McDevitt, E Doubrovina - Blood, 2004 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/104/8/2397/19086 Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted R Khanna , SR Burrows , J Nicholls - European journal of , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1521-4141(199802)28:02%3C451::AID-IMMU451%3E3.0.CO;2-U Identification and prevalence of CD8+ T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2 P Meij, A Leen , AB Rickinson - journal of cancer, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.10309 Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression N Kienzle, TB Sculley, L Poulsen, M Buck - Journal of , 1998 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.72.8.6614-6620.1998 Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin MK Gandhi, E Lambley, J Duraiswamy, U Dua, C Smith - Blood, 2006 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/108/7/2280/22499 Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design M Bharadwaj , M Sherritt, R Khanna , DJ Moss - Vaccine, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X01000858 Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China LHJ Lin HsiangJu, CJM Cherng JawMing - 2005 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20063099489 Vaccination with human papillomavirus type 16 E7 peptide with CpG oligonucleotides for prevention of tumor growth in mice KB Gendron, A Rodriguez - of Otolaryngology-Head , 2006 - jamanetwork.comhttps://jamanetwork.com/journals/jamaotolaryngology/article-abstract/484121 Delineating the role of CD4+ T cells in the activation of human cytomegalovirus-specific immune responses following immunization with Ad-gBCMVpoly vaccine J Zhong, R Khanna - Journal of general virology, 2010 - microbiologyresearch.orghttps://www.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.025742-0 Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma J Duraiswamy, M Sherritt, S Thomson - Blood, The Journal , 2003 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/101/8/3150/16661 Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates J Duraiswamy, JM Burrows, M Bharadwaj - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.13.7401-7410.2003 Processing of two latent membrane protein 1 MHC class I epitopes requires tripeptidyl peptidase II involvement J Diekmann, E Adamopoulou, O Beck - The Journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/183/3/1587/108484 24 In vivo purging and post transplant immunotherapy with rituximab produces durable remissions in patients with low grade and mantle cell lymphoma IW Flinn, L Diehl, E Garrett , D Carter-Brookins - Biology of Blood and , 2003 - core.ac.ukhttps://core.ac.uk/download/pdf/82621115.pdf Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China HJ Lin, JM Cherng, MS Hung, Y Sayion - Journal of biomedical , 2005 - Springerhttps://link.springer.com/article/10.1007/s11373-005-9017-y Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules FT Ilca, A Neerincx, MR Wills - Proceedings of the , 2018 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1809465115 Direct immunosuppressive effects of EBV-encoded latent membrane protein 1 DF Dukers, P Meij, MBHJ Vervoort, W Vos - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/2/663/32938 Antibody-mediated delivery of TAPBPR enables the redirection of virus-specific T cell responses to tumour cells A Neerincx, A Aflalo, I Hafstrand, AA Torres - 2022 - researchsquare.comhttps://www.researchsquare.com/article/rs-2357899/latest Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies A Demachi-Okamura, Y Ito , Y Akatsuka - European journal of , 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200535485

• Marca: Biosynth